# Oral Glyceryl Triacetate (GTA) in Newborns With Canavan

> **NCT00724802** · NA · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 1 (estimated)

## Conditions studied

- Canavan Disease

## Interventions

- **DIETARY_SUPPLEMENT:** GTA (Glyceryl triacetate)
- **DRUG:** GTA glyceryl triacetate

## Key facts

- **NCT ID:** NCT00724802
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2008-08
- **Final completion:** —
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2011-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724802, "Oral Glyceryl Triacetate (GTA) in Newborns With Canavan". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00724802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*